1. Assessment of MIC Increases with Meropenem-Vaborbactam and Ceftazidime-Avibactam in TANGO II (a Phase 3 Study of the Treatment of CRE Infections). (4th October 2017) Authors: Lomovskaya, Olga; Castanheira, Mariana; Vazquez, Jose; Kaye, Keith S; Nelson, Kirk; Sun, Dongxu; Alexander, Elizabeth; Dudley, Michael N; Yin, Michael Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Outcomes of Serious Infections due to Carbapenem-Resistant Enterobacteriaceae (CRE) in TANGO II, a Phase 3, Randomized, Multi-National, Open-Label Trial of Meropenem-Vaborbactam (M-V) Vs. Best Available Therapy (BAT). (4th October 2017) Authors: Kaye, Keith S; Vazquez, Jose; Mathers, Amy; Daikos, George; Alexander, Elizabeth; Loutit, Jeffrey S; Zhang, Shu; Dudley, Michael N; Cornely, Oliver Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Constitutional de novo deletion CNV encompassing REST predisposes to diffuse hyperplastic perilobar nephroblastomatosis (HPLN). Issue 9 (11th September 2020) Authors: Hyder, Zerin; Fairclough, Adele; Groom, Mike; Getty, Joan; Alexander, Elizabeth; van Veen, Elke M; Makin, Guy; Sethuraman, Chitra; Tang, Vivian; Evans, D Gareth; Maher, Eamonn R; Woodward, Emma R Journal: Journal of medical genetics Issue: Volume 58:Issue 9(2021) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Constructions of motherhood and fatherhood in newspaper articles on maternal and paternal postpartum depression. (11th April 2014) Authors: Alexander, Elizabeth; McMullen, Linda Journal: Gender and language Issue: Volume 9:Number 2(2015) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Issue 5 (May 2022) Authors: Self, Wesley H.; Sandkovsky, Uriel; Reilly, Cavan S.; Vock, David M.; Gottlieb, Robert L.; Mack, Michael; Golden, Kevin; Dishner, Emma; Vekstein, Andrew; Ko, Emily R.; Der, Tatyana; Franzone, John; Almasri, Eyad; Fayed, Mohamed; Filbin, Michael R.; Hibbert, Kathryn A.; Rice, Todd W.; Casey, Jonat... Journal: Lancet infectious diseases Issue: Volume 22:Issue 5(2022) Page Start: 622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Failure to Thrive and Respiratory Failure in an Adolescent Male. (December 2015) Authors: Knee, Samuel J.; Alexander, Elizabeth; Medar, Shivanand Journal: Clinical pediatrics Issue: Volume 54:Number 14(2015) Page Start: 1399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Global Value Chain Reconfiguration and COVID-19: Investigating the Case for More Resilient Redistributed Models of Production. (February 2022) Authors: Phillips, Wendy; Roehrich, Jens K.; Kapletia, Dharm; Alexander, Elizabeth Journal: California management review Issue: Volume 64:Number 2(2022) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials. (3rd June 2020) Authors: Lodise, Thomas P; Colman, Sam; Alexander, Elizabeth; Stein, Daniel S; Fitts, David; Goldberg, Lisa; Schranz, Jennifer Journal: Open forum infectious diseases Issue: Volume 7:Number 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LB6. Oral Lefamulin Is Safe and Effective in the Treatment of Adults With Community-Acquired Bacterial Pneumonia (CABP): Results of Lefamulin Evaluation Against Pneumonia (LEAP 2) Study. (26th November 2018) Authors: Alexander, Elizabeth; Goldberg, Lisa; Das, Anita; Moran, Gregory J; Sandrock, Christian; Gasink, Leanne B; Spera, Patricia; Sweeney, Carolyn; Paukner, Susanne; Wicha, Wolfgang W; Schranz, Jennifer Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Meropenem-Vaborbactam vs. Best Available Therapy for Carbapenem-Resistant Enterobacteriaceae Infections in TANGO II: Outcomes in Immunocompromised Patients. (4th October 2017) Authors: Paterson, David L; Kwak, Eun J; Bhowmick, Tanaya; Alexander, Elizabeth; Loutit, Jeffrey S; Zhang, Shu; Dudley, Michael N; Walsh, Thomas J Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗